Emergent BioSolutions acquires opioid overdose company

By Elizabeth S. Eaton | Aug 28, 2018 | 11:19 PM GMT

Biodefense company Emergent BioSolutions Inc. (NYSE:EBS) will acquire opioid overdose and addiction company Adapt Pharma Ltd. (Dublin, Ireland)